Home/Oncotherapy Science/Hatsuo Kato

HK

Hatsuo Kato

Chairman

Oncotherapy Science

Therapeutic Areas

Oncotherapy Science Pipeline

Drug	Indication	Phase
TOPK-Inhibitor	Cancer	Preclinical
MELK-Inhibitor	Cancer	Preclinical
Antibody Programs	Cancer	Preclinical
Cancer Vaccine Programs	Cancer	Preclinical

Leadership Team at Oncotherapy Science

Junichi Shimada

President & CEO

Yusuke Nakamura

Scientific Collaborator (Emeritus Professor)

View full Oncotherapy Science profile